Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin T Hayes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Addiction Science & Clinical Practice|February 5, 2025
"There's always somebody that you can identify with": a qualitative study of patient perspectives on buprenorphine group medical visitsMariya Masyukova, Benjamin T Hayes, Teresa López-Castro, et al.
Substance Use & Misuse|May 3, 2021
"The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed BuprenorphineBenjamin T Hayes, Andrea Jakubowski, Christine Fitzsimmons, et al.
Journal of Substance Use and Addiction Treatment|December 16, 2023
Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort studyBenjamin T Hayes, Phoebe Li, Tess Nienaltow, et al.
The International Journal on Drug Policy|October 7, 2021
Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection suppliesBenjamin T Hayes, Jamie Favaro, Dan Coello, et al.
Journal of Substance Use|April 5, 2024
NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service programBenjamin T Hayes, Jamie Favaro, Czarina N Behrends, et al.
Journal of Addiction Medicine|February 24, 2026
Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use DisorderAaron D Fox, Sarah E Messmer, Benjamin T Hayes, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
"It was good because they have a relationship with us:" A qualitative study on low-threshold buprenorphine treatment at syringe services programsEmma McGill, Benjamin T Hayes, Teresa López-Castro, et al.
Contemporary Clinical Trials Communications|January 22, 2026
MiBUP: A pilot randomized controlled trial of low-dose initiation of buprenorphine for opioid use disorder: Design and rationaleBenjamin T Hayes, Annika Sabado, Haruka Minami, et al.
Contemporary Clinical Trials|January 6, 2022
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationaleAndres Perez-Correa, Bilal Abbas, Lindsey Riback, et al.
Journal of Addiction Medicine|November 14, 2021
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and OutcomesAndrea Jakubowski, Brianna L Norton, Benjamin T Hayes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Addiction Science & Clinical Practice|February 5, 2025
"There's always somebody that you can identify with": a qualitative study of patient perspectives on buprenorphine group medical visitsMariya Masyukova, Benjamin T Hayes, Teresa López-Castro, et al.
Substance Use & Misuse|May 3, 2021
"The Doctor Says You Cannot Have [Buprenorphine]" Autonomy and Use of Prescribed or Non-Prescribed BuprenorphineBenjamin T Hayes, Andrea Jakubowski, Christine Fitzsimmons, et al.
Journal of Substance Use and Addiction Treatment|December 16, 2023
Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort studyBenjamin T Hayes, Phoebe Li, Tess Nienaltow, et al.
The International Journal on Drug Policy|October 7, 2021
Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection suppliesBenjamin T Hayes, Jamie Favaro, Dan Coello, et al.
Journal of Substance Use|April 5, 2024
NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service programBenjamin T Hayes, Jamie Favaro, Czarina N Behrends, et al.
Journal of Addiction Medicine|February 24, 2026
Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use DisorderAaron D Fox, Sarah E Messmer, Benjamin T Hayes, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
"It was good because they have a relationship with us:" A qualitative study on low-threshold buprenorphine treatment at syringe services programsEmma McGill, Benjamin T Hayes, Teresa López-Castro, et al.
Contemporary Clinical Trials Communications|January 22, 2026
MiBUP: A pilot randomized controlled trial of low-dose initiation of buprenorphine for opioid use disorder: Design and rationaleBenjamin T Hayes, Annika Sabado, Haruka Minami, et al.
Contemporary Clinical Trials|January 6, 2022
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationaleAndres Perez-Correa, Bilal Abbas, Lindsey Riback, et al.
Journal of Addiction Medicine|November 14, 2021
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and OutcomesAndrea Jakubowski, Brianna L Norton, Benjamin T Hayes, et al.
Pageof 2